Clinical Trials Browser

Withdrawn × INDUSTRY × amrubicin × Clear all

NCT00380835 2008-09-23

Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms